Brief: Biora Therapeutics - On June 6, Received Written Notice From Nasdaq Notifying Company That It Is Not In Compliance With Minimum Bid Price Requirements
10/06/2022 21:54
June 10 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS - ON JUNE 6, RECEIVED WRITTEN NOTICE
FROM
NASDAQ NOTIFYING COMPANY THAT IT IS NOT IN COMPLIANCE WITH
MINIMUM BID PRICE REQUIREMENTS
Further company coverage: BIOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules